Start each meal with protein before moving to vegetables and then carbohydrates
In preclinical studies, GIP and GLP1 reduce atherosclerosis
Even in India, early access to innovator brands like Novo Nordisk Ozempic and Wegovy (both semaglutide), plus Rybelsus, Victoza, and Trulicity, meant bills of 10,00020,000 per month for many patients, putting these drugs out of reach for the average middle-class household
Currently, only two GLP-1s are approved by the FDA to treat obesity: Wegovy and Saxenda (liraglutide)
Some individuals on weight loss medications experience hair loss, which is usually associated with rapid weight variation or an inadequate diet and not the medication itself
The following timeline represents general estimates